St. Jude Medical
This article was originally published in The Gray Sheet
Executive Summary
Physician warning issued relating to potential malfunction due to a microprocessor anomaly in "a very small number" of the firm's Trilogy family of pacemakers, firm reports March 10. Notification follows a July 1999 physician communication related to Trilogy line. Twenty out of roughly 144,000 devices currently on the market have been "reported to exhibit an inappropriate pacing mode change to single-chamber atrial pacing," the company explains. No patient injuries are reported
You may also be interested in...
St. Jude Tempo, Meta Pacer Advisory Calls For Replacement In Some Patients
"Significantly pacemaker-dependent" individuals implanted with certain Tempo and Meta pacemakers should have the devices replaced given the "potential for loss of pacing function," St. Jude Medical recommends in a June 7 physician advisory.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.